Jinglu Wang

Title: Jinglu Wang: Innovator in Pharmaceutical Science

Introduction

Jinglu Wang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical science, particularly through his innovative work on cyclic dinucleotide analogues. His research focuses on developing new therapeutic options for various diseases.

Latest Patents

Jinglu Wang holds 1 patent for his invention titled "Cyclic dinucleotide analogue, pharmaceutical composition thereof, and application." This patent describes a cyclic dinucleotide analogue that can be utilized as a regulator of a stimulator of interferon genes (STING). The invention has potential applications in treating and relieving multiple types of diseases, including malignant tumors, inflammations, autoimmune diseases, and infectious diseases. Additionally, the STING regulator can serve as a vaccine adjuvant, enhancing the efficacy of vaccines.

Career Highlights

Jinglu Wang is currently associated with Shanghai De Novo Pharmatech Co., Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and improving patient outcomes through novel pharmaceutical solutions.

Collaborations

Jinglu Wang collaborates with esteemed colleagues, including Zhaolong Tong and Ping Qin, who contribute to his research initiatives and help drive forward the mission of their organization.

Conclusion

Jinglu Wang's contributions to pharmaceutical science exemplify the impact of innovative research on healthcare. His work on cyclic dinucleotide analogues holds promise for addressing significant medical challenges.